Nrf2 inducers are currently being examined in several clinical trials for inflammatory lung conditions (NCT01335971, NCT04937855, NCT0315665), osteoarthritis (NCT04638387), and cancer (NCT03182959, NCT03872427. This evidence concerns the gene NFE2L2 and osteoarthritis.